Skip to main content

Advertisement

SpringerLink
Log in

Immunohistochemical Expression of Cell Proliferating Nuclear Antigen (PCNA) and p53 Protein in Cervical Cancer

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Objective

This study was designed to evaluate the immunohistochemical expression of proliferating cell nuclear antigen (PCNA) and p53 protein expression in preneoplastic and neoplastic lesions in uterine cervix.

Study Design

A total of 36 cervical biopsies were subjected for immunostaining and the results were correlated with different prognostic parameters. Bivariate and multivariate statistical analyses were done using “STATA” software.

Results

PCNA labeling index and p53 expression increased with increasing severity of CIN lesions. PCNA labeling index was maximum (46.0) carcinoma cervix with intense positive staining. In bivariate statistical analysis, p53 and PCNALI were found to be insignificant (0.4184 and 0.4328, respectively). Menopausal stage was significantly associated with CA and CIN groups (P < 0.166 and P < 0.049), respectively.

Conclusion

These markers may be of greater importance in low-grade CIN lesions showing high proliferative index. This will place the low-grade lesions in higher grade indicating the utility of proliferative markers in decision making for intervention. This method is simple and cost effective and may be useful in developing countries where HPVDNA testing is still out of reach because of high cost.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Globocan 2008 All Cancers (excluding non-melanoma skin cancer) Incidence and Mortality Worldwide in 2008.

  2. WHO/ICO Information Centre on HPV and Cervical Cancer. Available from http://www.who.int/hpvcentre. Cited May 5 2009.

  3. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285:1500–5.

    Article  PubMed  CAS  Google Scholar 

  4. Anttila A, Pukkala E, Soderman B, et al. Effect of organized screening on cervical cancer incidence and motality in finland, 1963–1995: recent increase in cervical cancer incidence. Int J Cancer. 1999;83:59–65.

    Article  PubMed  CAS  Google Scholar 

  5. Negri G, Vittadello F, Romano F, et al. P16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch. 2004;445(6):616–20.

    Article  PubMed  Google Scholar 

  6. McCluggage WG, Walsh MY, Thornton CM, et al. Inter and intra-observer variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system. Br J Obstet Gynaecol. 1998;105(2):206–10.

    Article  PubMed  CAS  Google Scholar 

  7. Chi CH, Rubio CA, Lagerlof B. The frequency and distribution of mitotic figures in dysplasia and carcinoma in situ. Cancer. 1977;39(3):1218–23.

    Article  PubMed  CAS  Google Scholar 

  8. Herbsleb M, Knudsen UB, Orntoft TF, et al. Telomerase activity, MIB-1, PCNA, HPV16 and p53 as diagnostic markers for cervical intraepithelial neoplasia. APMIS. 2001;109(9):607–17.

    Article  PubMed  CAS  Google Scholar 

  9. Lool ML, Dali AZ, Ali SA, et al. Expression of p53, bcl2 and Ki-67 in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. Anal Quant Cytol Histol. 2008;30(2):63–70.

    Google Scholar 

  10. Goel MM, Mehrotra A, Singh U, et al. MIB-1 and PCNA immunostaining as a diagnostic adjunct to cervical pap smear. Diagn Cytopathol. 2005;33:15–9.

    Article  PubMed  CAS  Google Scholar 

  11. Holem R, Skomedal H, Helland A, et al. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant and malignant tissues of the cervix uterine. J pathol. 1993;169:21–6.

    Article  Google Scholar 

  12. Turcuo L, Tezcan S, Kaygusuz G, et al. The role of p53, bcl2 and ki-67 in premalignant cervical lesions and cervical cancer. Eur J Gynaecol Oncol. 2007;28(4):290–3.

    Google Scholar 

  13. Cardillo MR, Stamp GW, Pignatelli MN, et al. Immunohistochemical analysis of p53 oncopotein and proliferating cell nuclear antigen (PCNA) in the cervix uteri. Eur J Gynaecol Oncol. 1993;14(6):484–90.

    PubMed  CAS  Google Scholar 

  14. Wang JL, Zheng BY, Li XD, et al. Predictive significance of the alteration of p161NK4A, p14ARF, p53 and proliferative cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res. 2004;10(7):2407–14.

    Article  PubMed  CAS  Google Scholar 

  15. Heatley MK. What is the value of proliferation markers in the normal and neoplastic cervix? Histol Histopathol. 1998;13(1):249–54.

    PubMed  CAS  Google Scholar 

  16. Astudillo H, Perez M, Silva J, et al. p53, Bcl-2, PCNA expression and apoptotic rates during cervical tumorigenesis. Ann N Y Acad Sci. 2003;1010:771.

    Article  PubMed  CAS  Google Scholar 

  17. Maeda MY, Simoes M, Wakamatsu A, et al. Relevance of the rates of PCNA, Ki-67 and p53 expression according to the epithelial compartment in cervical lesion. Gynecol Obstet Fertile. 2000;28(1):44–50.

    Google Scholar 

  18. Hall PA, Woods AL. Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tissue Kinet. 1990;23:505–22.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This study was financially supported by Indian Council of Medical Research, New Delhi.

Author information

Authors and Affiliations

  1. Department of Pathology, C.S.M. Medical University, Lucknow, UP, India

    Goel Madhumati (Professor), Somani Kavita (Ex Resident) & Mehrotra Raj (Professor & Head)

  2. Department of Pharmacology, C.S.M. Medical University, Lucknow, UP, India

    Mehrotra Anju (Senior Research Assistant)

  3. Department of Obstetrics & Gynecology, C.S.M. Medical University, Lucknow, UP, India

    Singh Uma (Professor)

Authors
  1. Goel Madhumati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Somani Kavita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mehrotra Anju
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Singh Uma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mehrotra Raj
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mehrotra Anju.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Madhumati, G., Kavita, S., Anju, M. et al. Immunohistochemical Expression of Cell Proliferating Nuclear Antigen (PCNA) and p53 Protein in Cervical Cancer. J Obstet Gynecol India 62, 557–561 (2012). https://doi.org/10.1007/s13224-012-0180-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-012-0180-6

Keywords

Search

Navigation